Navigation Links
Wellpartner Supports HIV/AIDS Community
Date:6/24/2015

NEW YORK and PORTLAND, Ore., June 24, 2015 /PRNewswire/ -- Wellpartner, Inc. congratulates AIDS Service Center NYC (ASCNYC) on its highly successful 2nd annual Broadway's Best in Drag event, which was held at Manhattan's Abrons Art Center on Monday, May 11. The event preceded NYC's Pride celebration scheduled for June 21-28.

Attendee and Wellpartner's Head of Marketing, Julee Whalin stated, "ASCNYC definitely puts the 'fun' in fundraising. I thoroughly enjoyed the evening—talent was out in abundance and I was really pulling for contestant Sasha Velour. However, I feel the right Queen did win in the end; congratulations DelightedToBeHere! We were proud to be there representing Wellpartner, as ASCNYC organizers did a phenomenal job putting this together.  We are pleased to sponsor this highly organized, resourceful and socially relevant organization."

ASCNYC billed the event as "a celebration of community and a chance for us to grow our reach and build awareness as well as have a fabulous evening and a lot of fun." Funds raised by ASCNYC help tens of thousands of New Yorkers living with HIV/AIDS and other chronic conditions achieve and maintain health, housing, recovery, and self-sufficiency.

We share a common interest in helping those with HIV/AIDS. Wellpartner's industry-leading, nationwide 340B program administration helps covered entities optimize 340B savings, while maintaining program integrity. The federal 340B drug discount program is a crucial lifeline for safety net providers, which includes HIV/AIDS clinics funded through the Ryan White program, providing access to lower-priced prescription drugs.

"As we carry out this vital work, we're thrilled to have Wellpartner in our community of Positive Change makers—and are grateful for their support. Our partnership with Wellpartner ultimately supports access to treatment and care to hundreds of New Yorkers living with HIV," said ASCNYC Executive Director/CEO, Sharen I. Duke.

Wellpartner plans a strong, national presence throughout 2015, at significant events and exhibitions relative to 340B-associated causes and programs. Visitors to the upcoming 340B Coalition Summer Conference in Washington, D.C. can speak live to company representatives at Booth #8 from July 13-15.  At the Conference, Wellpartner will be hosting a guest speaker Luncheon on Monday; a Stakeholder Breakfast on Tuesday followed by a Cocktail Party at the PDR that Tuesday evening immediately following adjournment. All are welcome.

About Wellpartner
Wellpartner is a leading provider of 340B contract pharmacy programs for a wide variety of safety net hospitals and clinics. And, through our nationally licensed URAC, ACHC and VIPPS accredited specialty pharmacy, Wellpartner dispenses pharmaceuticals to selected patients of these hospitals and clinics.

Wellpartner provides innovative 340B tools. The newest addition to our product powerhouse is AccessCompare™, the industry's first 340B audit tool that automates validation of 340B claims to Covered Entities employing multiple administrators. It joins our AccessIntegra™, another industry first: A 100% transparent reporting and analytics tool offering vital information on all aspects of a contract pharmacy program—from claims qualification, to inventory replenishment, to financial reconciliation. Our exclusive AccessConvergence™ is a gateway offering that enables Covered Entities' inclusion of previously "locked away" 340B specialty prescriptions.

Through our 340B program optimization products and services, Wellpartner maximizes savings on behalf of our customers, while minimizing risk. Wellpartner's thoroughly vetted 340B process has withstood numerous rigorous Health Resources and Services Administration (HRSA) audits, and no deficiencies have been found for areas within our authority to date.

Visit www.wellpartner.com for more information.

Contact: Wellpartner, Inc.
Julee Whalin, 212.547.5088
jwhalin@wellpartner.com

 


'/>"/>
SOURCE Wellpartner, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Role of Market Research Supports Need for Training and Development Programs
2. Merrimack Pharmaceuticals Phase 1 Research Supports MM-121 Potential For Investigation As Combination With Chemotherapy In Patients With Advanced Solid Tumors
3. Alzheimers Drug Discovery Foundation Supports Madera Biosciences to Advance Small Molecule Drugs that Upregulate apoE
4. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
5. New ADHD/Retina Research Supports a Cerebellar Origin, states Dr. Harold Levinson
6. Quartz Bio SA Supports Debiopharm Group Precision Medicine Bioinformatics
7. AdvaMed Supports Comprehensive Tax Reform Repeal of the Medical Device Tax Important First Step
8. BD Supports the FDAs Proposal to Reclassify Rapid Influenza Tests
9. seca Supports Obesity Therapy with the New medical Body Composition Analyzer
10. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
11. Equatorial Guinea Supports Malaria Vaccine Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... The American ... APNA Board of Directors and 2020 Nominating Committee . Elected by psychiatric-mental health nurse ... APNA 33rd Annual Conference in New Orleans, LA, October 2-5, 2019. , ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... solution needed to attract new customers, better engage existing patients and collaborate with ... digital marketing services in tandem with an all-in-one platform. With the Updox approach, ...
(Date:7/17/2019)... LOS ANGELES (PRWEB) , ... July 17, 2019 , ... ... Angeles to reclaim their smiles with Kanani's innovated bonding procedures. Bonding is just one ... other methods, bonding can be done in a single visit, and patients leave immediately ...
Breaking Medicine Technology:
(Date:7/17/2019)... SAN DIEGO (PRWEB) , ... July 17, 2019 , ... ... not become parents. Every Intended Parents’ story differs , but, in addition to ... their Surrogate. , Across the globe, more and more Intended Parents are electing to ...
(Date:7/17/2019)... ... July 17, 2019 , ... Dr. Jonathan Zaidan, MD, FACOG, President ... WJR’s Health Woman Show. The show airs on Wednesday, July 17ths at 7pm. ... , Dr. Zaidan and co-host Ann Thomas discuss the challenges that women face when ...
(Date:7/13/2019)... , ... July 12, 2019 , ... ... YCBD), has been named a “Brand to Watch” by Brightfield Group, a leading ... cbdMD in the top 10 of domestic CBD companies in two categories, Topicals ...
(Date:7/11/2019)... ... 2019 , ... Swagelok Southeast Texas, a distributor for Ohio-based ... acquisition of another Houston-area distributor. The acquisition of the Swagelok Central Houston facility ... Nederland and Houston. , With this expansion, Swagelok Southeast Texas also extends ...
(Date:7/10/2019)... ... 10, 2019 , ... HMP, a leader in healthcare events and education, today ... Pathways Congress, taking place October 11-13, 2019 in Boston. , Launched in 2016, the ... the expansion of clinical pathways as a decision support tool and their increasing influence ...
Breaking Medicine News(10 mins):